Lista de obras - Wai Tong Ng - Dominio Público Uruguay

A Mixed-Methods Study of Unmet Supportive Care Needs Among Head and Neck Cancer Survivors.

artículo científico publicado en 2017

A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity

artículo científico publicado en 2017

A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation

artículo científico publicado en 2013

A phase II study of pemetrexed combined with cisplatin in patients with recurrent or metastatic nanopharyngeal carcinoma.

artículo científico publicado en 2011

A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma

article

Adjuvant S-1 chemotherapy after curative resection of gastric cancer in Chinese patients: assessment of treatment tolerability and associated risk factors

artículo científico publicado en 2016

Adjuvant chemoradiation for resected gastric cancer: a 10-year experience

scientific article published on 17 February 2011

An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models.

artículo científico publicado en 2011

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

artículo científico publicado en 2018

Automatic segmentation for adaptive planning in nasopharyngeal carcinoma IMRT: Time, geometrical, and dosimetric analysis

scientific article published on 23 July 2019

COVID-19 pandemic: Effects and evidence-based recommendations for otolaryngology and head and neck surgery practice

artículo científico publicado en 2020

Can the analysis of ERCC1 expression contribute to individualized therapy in nasopharyngeal carcinoma?

artículo científico publicado en 2010

Challenges for Quality Assurance of Target Volume Delineation in Clinical Trials.

artículo científico publicado en 2017

Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer.

artículo científico publicado en 2017

Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant

artículo científico

Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies.

artículo científico

Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma

artículo científico publicado en 2010

Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review

artículo científico publicado en 2016

Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

artículo científico publicado en 2015

Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma

scientific article published on 06 May 2020

Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.

artículo científico publicado en 2015

Comparison of Planning Quality and Efficiency Between Conventional and Knowledge-based Algorithms in Nasopharyngeal Cancer Patients Using Intensity Modulated Radiation Therapy.

artículo científico publicado en 2016

Cost minimization analysis of capecitabine versus 5-fluorouracil-based treatment for gastric cancer patients in Hong Kong.

artículo científico publicado en 2017

Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement.

artículo científico publicado en 2011

Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis

artículo científico publicado en 2019

Current management of nasopharyngeal cancer.

artículo científico publicado en 2012

Dose volume effects of re-irradiation for locally recurrent nasopharyngeal carcinoma

scientific article published on 16 October 2019

Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.

artículo científico publicado en 2014

Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.

artículo científico publicado en 2014

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

artículo científico publicado en 2010

Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening

artículo científico publicado en 2008

Head and neck cancer in Hong Kong.

artículo científico publicado en 2017

IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.

artículo científico publicado en 2015

Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma.

artículo científico publicado en 2006

International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma

scientific article published on 02 July 2019

International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.

artículo científico publicado en 2017

Is selective neck irradiation safe for node-negative nasopharyngeal carcinoma?

artículo científico publicado en 2013

Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese

artículo científico publicado en 2018

Limitation of radiological T3 subclassification of rectal cancer due to paucity of mesorectal fat in Chinese patients

artículo científico publicado en 2014

Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.

artículo científico

Management of locally recurrent nasopharyngeal carcinoma

scientific article published on 21 August 2019

Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma

scientific article published on 25 October 2016

MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma

artículo científico publicado en 2017

N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: pattern of nodal involvement by radiological levels

artículo científico publicado en 2006

NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells

artículo científico publicado en 2015

NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma

artículo científico publicado en 2020

Nasopharyngeal carcinoma: salvage of local recurrence.

artículo científico

Parapharyngeal extension of nasopharyngeal carcinoma: still a significant factor in era of modern radiotherapy?

artículo científico publicado en 2008

Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT-A study by the HKNPCSG

artículo científico publicado en 2019

Perceived unmet supportive care needs and determinants of quality of life among survivors of head and neck cancer

Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.

artículo científico publicado en 2008

Potential pitfalls in incorporating plasma Epstein-Barr virus DNA in the management of nasopharyngeal carcinoma

scientific article published on 28 November 2019

Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiother

artículo científico publicado en 2014

Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy

artículo científico publicado en 2016

Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy

artículo científico publicado en 2015

Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.

artículo científico publicado en 2017

Quality of life in head and neck cancer survivors at 1 year after treatment: the mediating role of unmet supportive care needs.

artículo científico publicado en 2014

Radical radiotherapy for nasopharyngeal carcinoma in elderly patients: the importance of co-morbidity assessment

artículo científico publicado en 2011

Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.

artículo científico publicado en 2016

Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.

artículo científico publicado en 2013

Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG

artículo científico publicado en 2020

Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.

artículo científico publicado en 2008

Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?

artículo científico publicado en 2014

Special section on intensity-modulated radiation therapy for head and neck cancer (IMRT)

artículo científico publicado en 2018

The International Atomic Energy Agency global initiatives on nasopharyngeal cancer treatment

artículo científico publicado en 2016

The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT

artículo científico publicado en 2014

The prognostic value of histological typing in nasopharyngeal carcinoma

artículo científico publicado en 2011

Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin

artículo científico publicado en 2015

Translational research in nasopharyngeal carcinoma.

artículo científico

Treatment of Stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes

scientific article published on 01 November 2006

Treatment of primary liver cancer using highly-conformal radiotherapy with kV-image guidance and respiratory control.

artículo científico publicado en 2011

Trends and patterns of breast conservation treatment in Hong Kong: 1994-2007.

artículo científico publicado en 2008

What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.

artículo científico publicado en 2016

Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma

artículo científico publicado en 2016

Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.

artículo científico publicado en 2016

Lista de obras de Wai Tong Ng

A Mixed-Methods Study of Unmet Supportive Care Needs Among Head and Neck Cancer Survivors.

A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity

A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation

A phase II study of pemetrexed combined with cisplatin in patients with recurrent or metastatic nanopharyngeal carcinoma.

A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma

Adjuvant S-1 chemotherapy after curative resection of gastric cancer in Chinese patients: assessment of treatment tolerability and associated risk factors

Adjuvant chemoradiation for resected gastric cancer: a 10-year experience

An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models.

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Automatic segmentation for adaptive planning in nasopharyngeal carcinoma IMRT: Time, geometrical, and dosimetric analysis

COVID-19 pandemic: Effects and evidence-based recommendations for otolaryngology and head and neck surgery practice

Can the analysis of ERCC1 expression contribute to individualized therapy in nasopharyngeal carcinoma?

Challenges for Quality Assurance of Target Volume Delineation in Clinical Trials.

Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer.

Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant

Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies.

Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma

Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review

Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma

Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.

Comparison of Planning Quality and Efficiency Between Conventional and Knowledge-based Algorithms in Nasopharyngeal Cancer Patients Using Intensity Modulated Radiation Therapy.

Cost minimization analysis of capecitabine versus 5-fluorouracil-based treatment for gastric cancer patients in Hong Kong.

Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement.

Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis

Current management of nasopharyngeal cancer.

Dose volume effects of re-irradiation for locally recurrent nasopharyngeal carcinoma

Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.

Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening

Head and neck cancer in Hong Kong.

IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.

Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma.

International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma

International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.

Is selective neck irradiation safe for node-negative nasopharyngeal carcinoma?

Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese

Limitation of radiological T3 subclassification of rectal cancer due to paucity of mesorectal fat in Chinese patients

Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective.

Management of locally recurrent nasopharyngeal carcinoma

Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma

MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma

N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: pattern of nodal involvement by radiological levels

NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells

NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma

Nasopharyngeal carcinoma: salvage of local recurrence.

Parapharyngeal extension of nasopharyngeal carcinoma: still a significant factor in era of modern radiotherapy?

Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT-A study by the HKNPCSG

Perceived unmet supportive care needs and determinants of quality of life among survivors of head and neck cancer

Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.

Potential pitfalls in incorporating plasma Epstein-Barr virus DNA in the management of nasopharyngeal carcinoma

Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiother

Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy

Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy

Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.

Quality of life in head and neck cancer survivors at 1 year after treatment: the mediating role of unmet supportive care needs.

Radical radiotherapy for nasopharyngeal carcinoma in elderly patients: the importance of co-morbidity assessment

Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.

Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.

Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG

Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.

Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?

Special section on intensity-modulated radiation therapy for head and neck cancer (IMRT)

The International Atomic Energy Agency global initiatives on nasopharyngeal cancer treatment

The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT

The prognostic value of histological typing in nasopharyngeal carcinoma

Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin

Translational research in nasopharyngeal carcinoma.

Treatment of Stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes

Treatment of primary liver cancer using highly-conformal radiotherapy with kV-image guidance and respiratory control.

Trends and patterns of breast conservation treatment in Hong Kong: 1994-2007.

What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.

Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma

Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma.